Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR 4Filed 5 days ago

ABVC BIOPHARMA, INC. files final prospectus (424B4)

Open the sourceReported by SEC EDGAR 4, sec.gov, 13 November 2026, by SEC EDGAR 4

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Muhabbit only has the headline for this one. The full report is at sec.gov.

Named in this story

ABVC BioPharma, Inc.